Immunorock
Latest round
- Seed
Last raised
- Jul 2025
Total raised
- $2.3M
Investors
- 3
About Immunorock
a Immunorock, operates as a biopharmaceutical company that offers an oral vaccine platform that utilizes the properties of Bifidobacterium for mucosal immunization. In December 2025, Immunorock Co, Ltd., Ltd. and Kobe Shinkin bank. The company develops a cancer immunotherapy drug that uses an oral vaccine platform technology. It is developing an oral cancer treatment vaccine (B440) and a coronavirus preventive vaccine (BCOV332).
Who invested in Immunorock
3 investors across 3 rounds
See all investors in Immunorock
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Immunorock
Who invested in Immunorock?
Immunorock has 3 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Immunorock raised?
Immunorock has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Immunorock last raise money?
Immunorock's most recent round on record is a Seed, in Jul 2025.
What does Immunorock do?
a Immunorock, operates as a biopharmaceutical company that offers an oral vaccine platform that utilizes the properties of Bifidobacterium for mucosal immunization.
Where is Immunorock headquartered?
Immunorock is headquartered in Kobe-shi, Japan.
Which VCs invest in companies like Immunorock?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Peak XV Partners, MPCi and Luminous Ventures back biotechnology companies at Immunorock's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Immunorock? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.